SLTM  Solta Medical Inc

Exchange

NASDAQ

Sector

Health Care

Industry

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market Cap.

235.8M

Vuru Grade

19.88/100

Current Price

$2.92
+0.00 (+0.00%)

Growth Price

$1.86
Overvalued by 36.24%

Stability Price

$2.84
Fairly valued

Company Metrics

  • 162.22 P/E
  • 1.56 P/S
  • 1.71 P/B
  • 0.02 EPS
  • -0.79% Cash ROIC
  • 0.65 Cash Ratio
  • 0 / N/A % Dividend
  • 1.50M Avg. Vol.
  • 64.44M Shares
  • 235.8M Market Cap.

Company Description

Solta Medical, Inc. designs, develops, manufactures, and markets energy-based medical device systems for aesthetic applications. Its products include Thermage NXT and CPT systems that provide non-invasive treatment options for skin tightening and contouring, body shaping, and enhancement in the appearance of cellulite; Fraxel re:fine and Fraxel re:store systems, which offer treatments for skin con...
more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

Solta Medical explores sale after loss exceeds estimate
Reuters - Nov 12, 2013
Solta's plans to pursue a sale come after its financial results missed analysts' estimates for at least four quarters in a row, hurt by rapidly deteriorating sales of its medical devices due to competition. Rival Zeltiq Aesthetics Inc (ZLTQ.O), has ...
Solta Medical to evaluate strategic alternatives - MarketWatch
Solta Medical Reports Third Quarter 2013 Results and Actions Implemented to ... - PR Newswire (press release)
Valeant Acquires Solta Medical
Zacks.com - Dec 17, 2013
Valeant Pharmaceuticals International, Inc. (VRX - Analyst Report) has entered into a definitive agreement to acquire all of the outstanding common stock of Solta Medical, Inc. for $2.92 per share in cash or $250 million. The offer price of $2.92 per ...
Acquisition of Solta Medical, Inc. by Valeant Pharmaceuticals International ... - PR Newswire (press release)
Valeant to acquire Solta Medical for $236 million - Reuters
Solta Medical CEO steps down as company revamps sales strategy
San Francisco Business Times (blog) - Aug 6, 2013
Solta Medical Inc.'s top executive is leaving - with two years' salary and a consulting deal - after a disappointing second quarter and as the acquisitive cosmetic medical devices developer adjusts its sales strategy.
Solta Medical Reports Second Quarter 2013 Results - PR Newswire (press release)
Valeant Pharmaceuticals International, Inc. Completes Acquisition Of Solta ...
MarketWatch - Jan 23, 2014
... Pharmaceuticals International, Inc. ("Valeant") today announced the completion of the previously announced transaction in which a wholly-owned subsidiary of Valeant Pharmaceuticals International ("VPI") would acquire Solta Medical, Inc. SLTM ...
Solta Medical Inc (SLTM): Zeltiq Aesthetics And Solta Medical Are Likely In Play
Seeking Alpha - Nov 14, 2013
Solta Medical (SLTM) announced on Monday of this week that it has hired Piper Jaffray as its investment banker/financial advisor to potentially explore a sale of the company. We estimate that the company has been in a black-out period for about seven ...
Solta Medical Inc (SLTM): Is An Acquisition Of Solta Medical Imminent?
Seeking Alpha - Sep 25, 2013
In my last article concerning Solta Medical Devices (SLTM), I remarked several times how I feel the company has good assets and the potential to grab significant market share in various segments.
Solta Medical Inc (SLTM): Solta Medical Agrees To Be Acquired By Valeant, But ...
Seeking Alpha - Dec 23, 2013
On Monday, December 16th, Valeant (NYSE:VRX) submitted what for the time being, is the winning bid to acquire Solta Medical Devices (NASDAQ:SLTM). For some time now, we have been predicting that Solta would be acquired before the end of this year.
Solta Medical Inc (SLTM): Solta Medical Officially Hires An Investment Banker ...
Seeking Alpha - Nov 12, 2013
In the on-going saga of Solta Medical (NASDAQ:SLTM), the next chapter has been written, when on the company's earnings call yesterday it announced it has hired Piper Jaffray as its financial advisor/investment banker to explore strategic alternatives.
Dr. Edward W. Knowlton Resigns as a Director of Solta Medical, Inc.
PR Newswire (press release) - May 24, 2013
HAYWARD, Calif., May 24, 2013 /PRNewswire/ -- Solta Medical, Inc. (NASDAQ: SLTM), a global leader in the medical aesthetics market, today reported Dr.
Solta Medical Inc (SLTM): Voce Capital Pushes For Acquisition Of Solta Medical ...
Seeking Alpha - Aug 9, 2013
Written by Scott Matusow. Scott has a position in the company featured in this article. Merger and acquisition speculation is one of the most interesting and exciting elements of the stock market.
Voce Capital Pushes For Acquisition Of Solta Medical, Activist Investor David ... - Trefis